´ä3©vMuÅÜºØ ½Ã¸pµL¥D°Ê¤½¥¬ ¥@½Ã¦C¡uȱoª`·N¡v ¶Ç¬V¤O¥¼©ú©Î¨ã¡u§K¬Ì°k¶h¡v¯S©Ê
¡i©ú³ø±M°T¡j¬F©²¦Û¤W¤ë©³°_®e³\¦bµá«ß»«©M¦L¥§§¹¦¨±µºØ·s«¬«aª¬¯f¬r¬Ì]ªº¥~¶Ä¨Ó´ä¡A¦Ü¬Q¤é¦³99¦W¥~¶Ä©è´ä¡A¤J¦í«ü©wªº¯þÆWµ·ÄR°s©±Àˬ̡A¨Ãº²{¬ÛÃö½T¶E¡C¤@¦W45·³¥~¶Ä¦bµá«ß»«¤w¥´¨â°w¬ì¿³¡A¥»¤ë1¤é©è´ä«á½T¶E¡AÅç¥X±aL452RÅܲ§¯f¬r®è¡C¦¹¥~¡A¥@½Ãªñ¤é±N³Ì¥ý¦b«n¬ü¬wôÛ¤ñ¨Èµo²{ªº¡uMu¡vÅܺدf¬r¦C¬°¡uȱoª`·NÅܺءv¡A½Ã¥Í¸p¬Q¤é¦^ÂЬd¸ß®ÉÃÒ¹ê¡A¥»´ä¦Û6¤ë°_µo²{3©vMuÅܺØӮסA¨ä¤¤¤@¤H¤w¥´¨â°wBioNTech(´_¥²®õ)¡C½Ã¥Í¸p¦¹«e¨Ã¨S¥D°Ê¤½¥¬¬ÛÃö¸ê®Æ¡C
¦óüø¨}¡G9³B°ò¦]¬ðÅÜ ®Æ¼vÅT¬Ì]§ÜÅé
´ä¤j·P¬V¤Î¶Ç¬V¯f¤¤¤ßÁ`ºÊ¦óüø¨}¬Q¦b°Ó¥x¡m¦b´¸®Ôªº¤@¤Ñ¥Xµo¡nªí¥Ü¡A¼È®É¥¼¯à½T©wDelta©MMu¨âºØÅܺدf¬r¡Aþ¤@ºØ¶Ç¬V¤O§ó±j¡A¦ÓMuÅܺدf¬rªºS³J¥Õ³Ì¤Ö¦³9Ó¦ì¸m¦³°ò¦]¬ðÅÜ¡A¥]¬AN501Y¡BE484K¡BP681Hµ¥¡A°Ñ¦Ò¨ä¥LÅܺدf¬r¡A³o¨Ç¦ì¸mªº°ò¦]¬ðÅܹï¯f¬rªº¶Ç¬V©Ê¡B¥´¬Ì]«á²£¥Í¤¤©M§ÜÅéµ¥¡uªÖ©w·|¦³¼vÅT¡v¡C¥L«Øij½Ã¥Í¨¾Å@¤¤¤ß¤½¥¬¥»´äMuÅܺدf¬rªº¸ê®Æ¡AÅý¤½²³§ó¤F¸Ñ±¡úG¡C
¬Q¼W4©v¿é¤J¥þÄݵá¶Ä ¨â¤W¾÷«e¤wµo¯f
¥»´ä¬Q¼W4©v¿é¤JӮסA¥þÄݵá«ß»«¥~¶Ä¡A¥]¬A¤@¦W45·³¤k¤l¡A¦o©ó5¤ë©M6¤ë¦bµá«ß»«¥´¨â°w¬ì¿³¡A9¤ë1¤é©è´ä¡A±a¦³L452RÅܲ§¯f¬r®è¡C³Ò¤u³Bªí¥Ü¡A¨Ñ¦b·í¦a¥´°w¥~¶ÄÀˬ̪º¯þÆWµ·ÄR°s©±©Ò´£¨Ñªº¸ê®Æ¡A¦Ü¬Q¤é¦³99¦W¥~¶Ä¤J¦í¡C
¥t¥~3¦W½T¶E¥~¶Ä¤¤¡A¤@¤H¦«e¦b´ä¥´¨â°w¬ì¿³¡A¨â¤H¦b´ä¥´´_¥²®õ¡A¨ä¤¤¥´´_¥²®õªº¨â¤H¦b8¤ë31¤é¤wµo¯f¡A¤´©ó9¤ë1¤é©è´ä¡A3¤H¥þ³¡Åç¥XL452RÅܲ§¯f¬r®è¡C
¬Q½T¶Eªº4¤H¥þ³¡¼9¤ë1¤é¥Ñ±JÃú¤Ó¥¬v¯èªÅªº5J272¯è¯Z©è´ä¡C¦]À³4¤H½T¶E¡A¥B¯è¯Z¦³¤@¦W¼«È¥¼²Å¨¾¬Ì³W¨Ò¡A½Ã¥Í¸p¬Q«Å¥¬¡A±JÃú¤Ó¥¬v¯èªÅÀç¹Bªº«È¾÷·|³Q¸T¸14¤é¡A¦Ü¥»¤ë16¤é¡C
¦¹¥~¡A¥@½Ã¤W¤ë©³±NMuÅܺدf¬r¦C¬°¡uȱoª`·NªºÅܺءv(variant of interest)¡A·ÀI¯Å§O¸ûDeltaÅܺدf¬r©ÒÄݪº¡uȱoÃöª`ªºÅܺءv(variant of concern)§C¡C½Ã¥Í¸p¬Q¦^ÂЬd¸ß®Éªí¥Ü¡AºI¦Ü¬Q¤é¦@µo²{3©vÓ®×ÄÝMuÅܺدf¬r¡A§Y¡uB.1.621¡v¡C½¬d¸ê®Æ¡A3©vÓ®×¥]¬A¨â¦W6¤ë±qôÛ¤ñ¨È©è´äªº¨k¤k¡A¥H¤Î¤@¦W7¤ë±q¬ü°ê©è´äªº26·³¤k¤l¡A¨ä¤¤26·³¤k¤l¤µ¦~4¤ë©M5¤ë¤w¦b´ä¥´¨â°w´_¥²®õ¡C½Ã¥Í¸p¦¹«e¥¼¦³¤½¥¬MuÅܺدf¬r¤w¬y¤J»´ä¡C
¾Ú¥@½Ã³Ì·s¤@´Á¬Ì±¡©P³ø¡AMuÅܺدf¬r³Ì¦©ó1¤ë¦b«n¬ü¬w°ê®aôÛ¤ñ¨Èµo²{¡AºI¦Ü8¤ë©³¡A¥þ²y39Ó°ê®a¤wµo²{¶W¹L4500©v¬ÛÃöӮסA¸ÓÅܺدf¬r¦³¥i¯à¨ã¡u§K¬Ì°k¶h(immune escape)¡v¯S©Ê¡A¦ý¤´»Ý§ó¦h¬ã¨s¤~¯à§ó¤F¸Ñ¸ÓÅܺدf¬rªº¯S©Ê¡C
©ú³ø°OªÌ
(·s«a¬Ì±¡)
¡½©ú³ø³ø®Æ¼ö½u¡Rinews@mingpao.com / 9181 4676